Fibrinogen-Binding Inhibitor Peptide

hhlggakqagdv ; 29: pn: wo0155210 seqid: 29 unclaimedsequence ; 16: pn: us20040191249 seqid: 16 claimed sequence ; fibrinogen y-chain dodecapetide ; fibrinogen gamma-chain dodecapeptide ; fibrinogen-binding inhibitor peptide ; l-valine,n-[n-[n-[n-[n2-[n2-[n-[n-[n-[n-(n-l-histidyl-l-histidyl)-l-leucyl]glycyl]glycyl]-l-alanyl]-l-lysyl]-l-glutaminyl]-l-alanyl]glycyl]-l-a-aspartyl]- ; 6: pn: wo0066182 seqid: 1 claimedprotein ; 10: pn: jp2002320666seqid: 10 claimed protein ; 7: pn: us20060046271 seqid: 19 unclaimed sequence ; fibrinogen g-chain fragment analog ; h-his-his-leu-gly-gly-ala-lys-gln-ala-gly-asp-val-oh ; human fibrinogen-gamma fragment 400-411 ; 125: pn: wo2008058016 seqid: 126 claimed protein ; 1: pn: wo2004069862 seqid: 1unclaimed sequence ; 32: pn: us6790606 seqid: 29 unclaimed sequence ; 24: pn: wo2004069875 page: 69 claimed sequence ; human fibrinogen g-400-411 peptide ; 3: pn: wo02072619page: 8 unclaimed sequence ; his-his-leu-gly-gly-ala-lys-gln-ala-gly-asp-val ; 15: pn: us20070065361seqid: 16 unclaimed sequence ; 1: pn: us7049140 seqid: 1 claimed protein ; 126: pn: us20030225251 seqid: 134 claimed sequence ; fibrinogen-γ fragment 400-411 ; 4:pn: wo2005035002 page: 8 unclaimed sequence ; fibrinogen binding inhibitory peptide ; 29: pn:us7521540 seqid: 29 unclaimed sequence ; l-valine,l-histidyl-l-histidyl-l-leucylglycylglycyl-l-alanyl-l-lysyl-l-glutaminyl-l-alanylglycyl-l-a-aspartyl- ; 4: pn: wo2004058305 page: 39 claimed protein